suPARnostic® TurbiLatex is now set to enhance clinical decision-making in the Emergency Department at Complejo Asistencial Universitario de León (León Hospital) in Spain. This marks the first implementation of suPARnostic® in Spanish hospitals, representing a significant step forward in integrating advanced diagnostics into patient care.

León Hospital, a 1,056-bed university medical center located in Spain’s Castilla y León region, is set to incorporate suPAR as a standard marker in the triage process for acute medical patients. This initiative aims to streamline patient management and minimize unnecessary hospital admissions.
Furthermore, suPARnostic® will be employed to assist in the triage of patients admitted with suspected COVID-19 infection, enhancing the accuracy and efficiency of diagnosing and managing these cases. This implementation underscores the hospital’s commitment to leveraging advanced biomarkers to improve patient care and operational efficiency.

Jakob Knudsen, CEO of ViroGates, expresses enthusiasm for a long-term partnership with León Hospital. He emphasizes the critical role of suPARnostic® in supporting triage procedures in the Emergency Department. Knudsen also highlights the importance of assisting León Hospital during the COVID-19 outbreak, aiming to enhance their capacity to manage the substantial patient influx and optimize resource allocation effectively.